ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

IL-17-Producing CCR6+CD4+ Th17 Cells Drive Intestinal Allograft Rejection in Humans.

J. Kaiser, C. Cosentino, A. Shukla, C. Desai, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein, A. Kroemer.

MedStar Georgetown Transplant Institute, Washington DC.

Meeting: 2016 American Transplant Congress

Abstract number: 554

Keywords: Intestinal transplantation, Rejection, T helper cells, Transcription factors

Session Information

Date: Tuesday, June 14, 2016

Session Name: Concurrent Session: Small Bowel Transplantation

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:54pm-5:06pm

Location: Room 102

Related Abstracts
  • Th17-Mediated Alloimmune Responses Play a Key Role in Intestinal Allograft Rejection in Humans
  • Eomes-Expressing CD8+ T Cells and Th17 Cells Mediate Costimulatory Blockade-Resistant Allograft Rejection in Mice

A. Allograft rejection remains a significant source of mortality and morbidity in intestinal transplant (ITx) recipients. However, the underlying mechanisms remain unclear. The purpose of this study was to test the hypothesis that Th17-mediated alloimmune responses play a major role in the pathogenesis of intestinal transplant (ITx) rejection in humans.

B. We obtained ITx allograft biopsies from recipients with acute cellular rejection (ACR), as well as a control ITx cohort with normal biopsies. Phenotypic analysis of cells was conducted by polychromatic flow cytometry and IHC. Graft-infiltrating cells were flow-sorted and real-time PCR (rtPCR) was performed to investigate effector cytokine and transcriptional factor profiles.

C. Our previous studies suggested that ITx allograft rejection may be critically mediated by CCR6 expressing Th17 cells as indicated by markedly elevated expression of Th17 related transcription profile in ACR versus pre-rejection control biopsy samples. Based on this we tested the hypothesis that CCR6+ Th17 are truly mediating ITx allograft rejection by analyzing CD4+/CCR6+ T-cells in ACR versus healthy control recipients via flow cytometry. Importantly, we found a significant increase in CCR6+ Th17 cells in rejection versus control bxs (55.6% v 26%, p<0.05). This Th17 phenotype was specific for allograft rejection since recipients with active allograft infections did not show such an increase in Th17 cells. Further subset analyses of flow-sorted CD4+/CCR6+ cells confirmed high expression levels of the hallmark transcription factor RORα and the signature effector cytokine IL-17, corroborating that IL-17 producing CCR6+ cells drive ITx rejection. Finally, we tested the hypothesis that proinflammatory dendritic cells induce Th17 responses in ITx by studying flow-sorted intestinal CX3CR1+ myeloid dendritic cells, which are implicated in regulating proinflammatory T-cell alloimmune responses. We found a pro-inflammatory Th17-related mRNA profile in the flow sorted dendritic cells as indicated by high expression of IL-1β, IL6, IL-23, and TNFα, suggesting that proinflammatory CX3CR1+ dendritic cells induce Th17-mediated responses to allograft rejection.

D: In conclusion, this study shows that Th17-mediated alloimmune responses play a significant role in intestinal allograft rejection in humans, which is of high clinical significance.

CITATION INFORMATION: Kaiser J, Cosentino C, Shukla A, Desai C, Girlanda R, Hawksworth J, Matsumoto C, Zasloff M, Fishbein T, Kroemer A. IL-17-Producing CCR6+CD4+ Th17 Cells Drive Intestinal Allograft Rejection in Humans. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kaiser J, Cosentino C, Shukla A, Desai C, Girlanda R, Hawksworth J, Matsumoto C, Zasloff M, Fishbein T, Kroemer A. IL-17-Producing CCR6+CD4+ Th17 Cells Drive Intestinal Allograft Rejection in Humans. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/il-17-producing-ccr6cd4-th17-cells-drive-intestinal-allograft-rejection-in-humans/. Accessed March 1, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Enhanced Recovery after Surgery Protocols in Kidney Transplantation: Time to Change Practice?
  • Efficacy of Filgrastim in Solid Organ Transplant Recipients
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • #16789 (not found)
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.